🇺🇸 Amlodipine (Norvasc) in United States

68 US adverse-event reports

Safety signals — FAERS

Adverse reaction reports describe suspected side effects. A report does not mean the drug caused the event — co-medications, underlying disease and coincidence all contribute.

Most-reported reactions

  1. Asthenia — 9 reports (13.24%)
  2. Hyperglycaemia — 9 reports (13.24%)
  3. Blood Glucose Increased — 8 reports (11.76%)
  4. Diarrhoea — 7 reports (10.29%)
  5. Drug Ineffective — 6 reports (8.82%)
  6. Dyspnoea — 6 reports (8.82%)
  7. Fall — 6 reports (8.82%)
  8. Fatigue — 6 reports (8.82%)
  9. Nausea — 6 reports (8.82%)
  10. Pruritus — 5 reports (7.35%)

Source database →

Other Cardiovascular approved in United States

Frequently asked questions

Is Amlodipine (Norvasc) approved in United States?

Amlodipine (Norvasc) does not currently have US marketing authorisation in our dataset.

Who is the marketing authorisation holder for Amlodipine (Norvasc) in United States?

Bayer is the originator. The local marketing authorisation holder may differ — check the official source linked above.